Access to quick, reliable, and repeated testing has been one of the greatest challenges for businesses, institutions, and individuals during the SARS-CoV-2 crisis. HOK has partnered with Germfree Laboratories to design a mobile testing lab that will help large organizations to meet this urgent need. These self-contained biocontainment facilities can provide advanced, onsite capabilities for any setting.
Genomic Partnership Wales is planning to construct a research facility in Cardiff in the United Kingdom to accelerate the development of pharmaceutical therapies. Created by a consortium of government, academic, and medical partners, the project involves the redevelopment of an existing two-story building to provide leading-edge genetics labs, seminar rooms, treatment suites, offices, freezer rooms, and support. The facility will include CL2 biocontainment research suites to ensure compliance with the UK's HBN 15 regulations for pathology services.
Allentown, an industry leader in research animal housing solutions, is offering a webinar on May 20, 2020. "Benefits of Biocontainment" will address the global challenges facing the animal housing industry and the ways in which biocontainment protocols can help address some of these issues when employed in the Allentown BCU-2 IVC and Cage system.
The webinar will be aired in two sessions at 10:00 AM and 1:00 PM EDT.
To register, visit Allentown, Inc.
E4H Architecture presented a webinar on modular facilities for accelerating vaccine development on May 8, 2020. Now available as an on-demand recording, the exciting session is led by Jeff Schantz, Director of Health Sciences and Technology at E4H. Jeff reviews planning strategies for adapting multi-therapeutic cGMP/BSL-3 cleanroom modules for SARS-CoV-2 response and cell therapy development. Presentation topics include regulatory guidelines, HVAC requirements, design and flow considerations, and decontamination strategies.
Tecniplast is offering a webinar on the use of the DVC® System to optimize animal modelling in mouse vivaria. “Improving Animal Modelling with 24/7 Home Cage Monitoring in Bio-exclusion/Biocontainment Mouse Housing Systems” will detail how the DVC® technology applied to the ISO caging system can deliver improved data replicability, animal welfare, and research results.
The Vaccines Manufacturing Innovation Centre (VIMC) is being constructed on an accelerated schedule in Oxford in the United Kingdom. Ground was broken on the £66 million project in April of 2020 and occupancy is expected in 2021, a year earlier than previously planned.
Price Industries is significantly increasing production of its air filtration systems in response to the SARS-CoV-2 pandemic. Instantly creating a negative-pressure isolation room, the company's fan filter unit can draw airborne virus out through a biosafety filter for expulsion through the building's exhaust vent or directly to the outside. The units can dramatically reduce airborne virus in healthcare environments such as nursing stations and temporary hospitals, and can even be used in hotel rooms that have been repurposed as care facilities.
The International WELL Building Institute (IWBI) has assembled a task force to address the role of the built environment in reducing the impact of SARS-CoV-2 and other respiratory infections. Aiming to define the critical role that buildings, organizations, and communities play in infectious disease management, the work will take a broad approach in considering both new and recurring agents that can affect large populations.
The Australian government has awarded AUD$220 million in federal funding to the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for upgrades to its biocontainment research facilities in Geelong. Constructed 35 years ago, the Australian Centre for Disease Preparedness (formerly the Australian Animal Health Laboratory) is a secure campus with four laboratory structures offering BSL-4 research space.
VACUUBRAND is offering continuing education courses approved by the American Institute of Architects and Green Business Certification Inc. Providing engineers and designers with the skills to create sustainable, high-performance laboratories, each course is available as a general webinar, a private webinar, or as an on-demand learning experience. AIA members will receive one LU/HSW (Health-Safety-Welfare learning unit) for each one-hour course.
ASHRAE, the American Society of Heating, Refrigerating and Air-Conditioning Engineers, has created an epidemic task force to respond to the global SARS-CoV-2 pandemic and provide guidance on how to ensure that buildings are prepared for current and future epidemics. The ASHRAE Epidemic Task Force has been established to deploy ASHRAE’s technical resources to address the impact of HVAC systems on disease transmission in healthcare facilities, workplaces, homes, public spaces, and recreational environments.
Georgia State University is planning to construct an $84 million research building in Atlanta for the study of global infectious diseases. Designed by HOK, the 84,100-sf biocontainment facility will provide BSL-3 and BSL-4 labs, a vivarium, collaborative open research areas, offices, and support space. A design-bid-build contractor is being sought for the project, which has an estimated construction cost of $66 million. The structure represents the third phase of development at the university's Science Park and is slated for completion in 2022.
Oklahoma State University is planning to break ground in spring of 2021 on a $100 million facility for the College of Agriculture in Stillwater. Designed to promote hands-on, experiential learning, the building will offer flexible teaching and research labs, dynamic classrooms, collaboration spaces, and faculty offices. Occupancy is expected in fall of 2023. OSU is also building the $7.1 million Animal Nutrition and Physiology Center.
An “onion skin” layout of lab adjacencies and biocontainment strategies derived from a thorough risk assessment process are highlights of the new construction for the South Dakota Animal Disease Research and Diagnostic Laboratory (ADRDL) in Brookings, S.D. The new 84,000-gsf (41,000-nsf) building, an addition to the original facility, will provide space to accommodate the burgeoning demand for molecular diagnostics while bringing activities on both sides of the ADRDL mission—research and diagnostics—under one roof.
HALIX opened a 72,000-sf biopharmaceutical development and manufacturing center in November of 2019 at Leiden Bio Science Park in the Netherlands. The five-story structure provides BSL-2 cleanrooms with unidirectional process flows that can easily be upgraded to BSL-3 as needed. A manufacturing line with a 250-liter bioreactor capacity supports the production of viral vaccines and viral vectors, while a separate protein manufacturing area accommodates single-use bioreactors with a capacity of up to 1,000 liters.
